Search for Clinical Trial Results
Ovarian Epithelial Cancer - 25 Studies Found
Status | Study |
Terminated |
Study Name: A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy Condition: Epithelial Ovarian Cancer Date: 2013-03-18 Interventions:
|
Completed |
Study Name: Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer Condition:
|
Recruiting |
Study Name: Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma Condition: Ovarian Carcinoma Date: 2014-11-19 |
Not yet recruiting |
Study Name: Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer. Condition: Epithelial Ovarian Cancer Date: 2017-05-13 Interventions: Diagnostic Test: methylation markers screening ctDNA extraction from plasma samples;bisulfite-treated DN |
Completed |
Study Name: FES-PET to Determine ER-expression in Epithelial Ovarian Cancer Condition: Epithelial Ovarian Cancer Date: 2011-09-20 Interventions: Other: FES-PET Patients undergo FES-PET prior to obtaining histology |
Terminated |
Study Name: Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy Condition: Ovarian Carcinoma Date: 2010-08-01 Interventions: Drug: Cytophosphan, Celecoxib, Methotrexate Metronomic Che |
Completed |
Study Name: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma Condition: Ovarian Carcinoma Date: 2008-07-23 Interventions: Dietary Supplement: Double-Brewed Green Tea liquid, 4 celsius; 500 mL ID, 3 hours after meals and 1 hour |
Completed |
Study Name: Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs. Condition: Epithelial Ovarian Cancer Date: 2014-12-11 Interventions: Other: Gynecological consultation |
Completed |
Study Name: Safety of Active Immunotherapy in Subjects With Ovarian Cancer Condition: Ovarian Epithelial Cancer Date: 2011-09-14 Interventions:
|
Recruiting |
Study Name: REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression Condition: Ovarian Carcinoma Date: 2015-07-29 Interventions:
|